ERBB2 and neoplasm: Tumor biology (ER/PR/HER2 status, histologic grade, proliferation) is foundational; higher grade and elevated Ki-67 frequently track with higher pCR rates, particularly in non-luminal disease, although cut-offs and assay variability limit routine decision thresholds [2,8,9,10].